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Abstract
Germline transcription has been described for both immunoglobulin and T-cell receptor (TCR) genes, raising questions of their functional signifi-
cance during haematopoiesis. Previously, an immature murine T-cell line was shown to bind antibody to TCR-Vb8.2 in absence of anti-Cb anti-
body binding, and an equivalent cell subset was also identified in the mesenteric lymph node. Here, we investigate whether germline
transcription and cell surface Vb8.2 expression could therefore represent a potential marker of T-cell progenitors. Cells with the TCR phenotype
of Vb8.2+Cb are found in several lymphoid sites, and among the lineage-negative (Lin) fraction of hematopoietic progenitors in bone marrow
(BM). Cell surface marker analysis of these cells identified subsets reflecting common lymphoid progenitors, common myeloid progenitors and
multipotential progenitors. To assess whether the LinVb8.2+Cb BM subset contains hematopoietic progenitors, cells were sorted and adop-
tively transferred into sub-lethally irradiated recipients. No T-cell or myeloid progeny were detected following introduction of cells via the intrathy-
mic or intravenous routes. However, B-cell development was detected in spleen. This pattern of restricted in vivo reconstitution disputes
LinVb8.2+Cb BM cells as committed T-cell progenitors, but raises the possibility of progenitors with potential for B-cell development.
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Introduction
Germline transcription is the production of mRNA transcripts from
either the unrearranged T-cell receptor (TCR) or immunoglobulin (Ig)
loci that are in ‘germline’ configuration. A common view has been that
production of germline transcripts is tightly coupled to rearrangement
events that take place at these loci to produce a functional TCR or B-
cell receptor (BCR). By this scenario, one would expect germline tran-
scripts to be produced at VDJ recombination when the chromatin is
open and fully accessible to transcriptional machinery. However,
germline TCR-Vb transcripts have been identified in early murine T
cells well before the TCR-Vb rearrangement event in RAG/ mice
where no TCR rearrangement occurs [1–3], and in cell subsets and
cell lines expressing fully rearranged TCR genes [2, 4, 5]. This evi-
dence refutes a model that associates germline transcription uniquely
with the TCR rearrangement event. In addition, germline transcripts
are generally thought to be sterile and non-functional. However, ear-
lier antibody binding experiments have suggested that these tran-
scripts encode and present a truncated TCR-Vb molecule on the cell
surface in the absence of a Cb region. Cells of the C1-V13D line bind
antibody to Vb8.2 but not Cb [2]. A small subset of cells with the
Vb8.2+Cb phenotype was later identified in the mesenteric lymph
node of DBA/2J mice (~4%). This was strain specific with a lower
1.4% found in SJL/J mice [6].
Several unusual TCR and Ig receptor structures have been identi-
fied as evidence of germline-encoded proteins and novel TCR struc-
tures. For example, germline-encoded IgVH proteins have been
reported [7]. Dual expression of TCRab structures functionally
responsive to Staphylococcus enterotoxin B have been identified in
mice [8] and humans [9, 10]. Dual TCRc chain receptor expression
has also been reported [11], along with cell surface expression of a
rearranged TCR-Vb chain in the absence of pTa or CD3 [12]. TCR-Vb
expression can occur on the cell surface as a structure differing from
the conventional TCRab receptor.
The expression of germline TCR-Vb8 transcripts has been docu-
mented in both early B and T-cell subsets and cell lines like C1-V13D
[4, 6]. In mice, germline-encoded TCR-Vb is detectable in multiple
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lymphoid tissues including mesenteric lymph node, spleen, thymus
and bone marrow (BM) [13]. While in vivo subsets expressing Vb8
but not Cb determinants have been identified, there is little known
about them. The developmental changes reported to occur in C1-
V13D cells following intrathymic passage suggest that this cell line
represents immature lymphoid cells that can differentiate along the T-
cell lineage. Since germline transcripts occur during early lymphopoi-
esis [1, 4], an important question is whether germline transcription
and germline-encoded TCR proteins represent markers of T lymphoid
lineage commitment. Here, we investigate the presence of Vb8+Cb
cells in mouse thymus, BM, lymph node and spleen. The subset of
lineage (Lin)Vb8+Cb cells in BM has been further analysed for
expression of markers which define hematopoietic progenitors, and
their capacity to differentiate and produce T-cell progeny upon adop-
tive transfer in mice. While we found no evidence of T-cell reconstitu-
tion, the lymphoid characteristics of this progenitor subset were
supported by specific production of mature B cells in spleen.
Materials and methods
Animals and tissue isolation
C57BL/Ka and C57BL/Ka-Thy1.1 (BA) mice expressing either Ly5.1 or
Ly5.2 were bred and maintained in Research Animal Facility at Stanford
University according to approved protocols. Male and female mice were
used at 4–8 weeks of age. Mice were killed by CO2 asphyxiation.
Spleen, thymus and BM were aseptically removed from 5 to 10 mice
for preparation of cell suspensions. For isolation of hematopoietic cells
from BM, femur and tibia of hind legs were removed, excess tissue dis-
carded, and the bones crushed in a small volume of medium PBS/2%
fetal calf serum. Additional medium was added until all BM cells were
released away from bone fragments.
Cell surface antibody staining
Spleen, thymus and lymph node cells were dissociated, and the cell
suspension filtered through nylon mesh. Red blood cells were removed
using lysis buffer (150 mM NH4Cl, 100 mM KHCO3, 0.1 mM Na2EDTA,
pH 7.2–7.4) followed by washing in PBS/2%FCS. Cells were stained
with antibody either directly with fluorochrome-conjugated antibodies,
or indirectly with a purified antibody followed by a second stage conju-
gate. Antibodies and their specificity are shown: TCR-Vb8.1/8.2
(MR5.2), TCR-Cb (H57-597), Thy1.1 (19EX5), NK1.1 (PK136), B220
(RA3-6B2), Ly5.1 (ALI-4A2), Ly5.2 (A20.1.7), CD127 (A7R34), Sca-1
(E13-161-7), c-Kit (2B8), CD4 (GK1.5), CD8 (53-6.7), CD3e (KT31.1),
TCRcd (GL3), I-Ab (AF6-120.1), CD11c (HL3), CD44 (IM7), CD25 (7D4),
CD19 (MB19-1), Mac-1 (M1/70) and Gr-1 (8C5). All antibodies were
purified from hybridoma culture supernatants with the exception of anti-
bodies specific for CD11c, CD25, CD44, TCRcd, I-Ab, NK1.1, TCR-Cb,
TCR-Vb8.1/8.2 and Ter119 purchased from BD Biosciences Pharmingen
(San Jose, CA, USA). Anti-CD19 antibody was purchased from eBio-
sciences (San Diego, CA, USA). Secondary antibody conjugates used
included Streptavidin-PE and Streptavidin-Cy7PE from Invitrogen (Carls-
bad, CA, USA).
Following staining, cells were resuspended in PBS/2%FCS containing
1 lg/ml of propidium iodide (PI) to detect dead cells by flow cytometry.
Normal BM cells were stained to set PI gates for sorted and depleted
BM subsets. Cells were analysed for up to 5-colour staining using a
FACS Vantage SE (Becton Dickinson, San Jose, CA, USA), and CellQuest
Pro software (Becton Dickinson). Viable cells (PI) were gated using
side scatter (SSC), and investigated for marker expression or sorted for
cell subset isolation. For isolation of rare cell subsets, sorted cells were
checked flow cytometrically and resorted to ensure high purity.
Lineage depletion of cells
Depletion of cells of known lineage (Lin+) from BM involved staining
cells with purified antibodies specific for known cell lineage markers.
Antibodies used were specific for Thy1.1 (19XE5), CD3e (KT31.1), CD4
(GK1.5), CD5 (53-7.3), CD8 (53-6.7), B220 (RA3-6B2), Mac-1 (M1/70),
Gr-1 (8C5) and Ter119). Following antibody staining, cells were washed
and incubated with magnetic Dynabeads (#M-450) Sheep anti-Rat IgG
(Dynal, Mount Waverley, VIC, Australia) at 4°C. A magnetic field was
applied and the supernatant collected. The procedure was repeated.
Cells were resuspended in 400 ll PBS/2%FCS containing goat F(ab’)2
anti-Rat IgG (H+L) conjugated to Cy5PE and incubated on ice for
20 min. Washed cells were resuspended in 400 ll of PBS/2%FCS con-
taining 50 ll of rat IgG as a blocking antibody. Cells were incubated for
10 min on ice and the Lin cell population then stained with antibody.
In vivo differentiation studies
To test whether LinVb8+Cb cells in BM contained T-cell progenitors,
sorted cells were adoptively transferred in vivo and their progeny devel-
oping in spleen and thymus assessed. BM cells of LinVb8+Cb pheno-
type which had been sorted and resorted from BA(Ly5.1) mice were
injected into C57BL/Ka-Ly5.2 sub-lethally irradiated hosts (4.75 Gy).
Mice were given 500 cells either (a) intravenously through the orbital
plexus, or (b) intrathymically, into a single thymic lobe [14]. Control
mice were given either hematopoietic stem cells (HSC; Kit+LinSca+
KLS) or LinVb8Cb cells, also sorted out of BM. Post transplanta-
tion, mice were maintained on water containing polymyxin B sulphate
(106 U/ml) and neomycin sulphate (1.1 g/l). Mice were killed at
4 weeks, and cells stained with antibodies to detect hematopoietic cell
types among donor-derived progeny. This time was chosen as a com-
promise between time for detection of T-cell progeny of common lym-
phoid progenitors (CLP) which occurs between 14 and 28 days [15],
and for early development of T cells from hematopoietic stem cells or
multipotential progenitors (MPP) which can be detected from as early
as 3 weeks [16].
Results
Characterization of Vb8+Cb cells in lymphoid
tissues
The prevalence of Vb8+Cb cells was analysed flow cytometrically
in thymus, BM, mesenteric lymph nodes and spleens of C57BL/6-
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Ly5.1 (BA) mice. To avoid any steric hindrance, cells were first
incubated with anti-Cb antibody, followed by anti-Vb8, an isotype
control antibody or no antibody. Cells were stained with antibodies
specific for lineage and stem cell markers to further define the
Vb8+Cb subset. Live cells were gated as PI negative (PI) cells,
and the Vb8+CbB220 cell population identified (Fig. 1). Cells
showed no expression of the lineage markers NK1.1, Thy1.1 and
B220, reflecting natural killer cells, T cells and B cells, respectively.
In mesenteric lymph node of BA mice, 5% of cells were
Vb8+B220. Most of these were mature Vb8+Cb+ T cells with 1%
asVb8+CbB220 cells, reflecting 0.05% of total mesenteric lymph
node (Fig. 1). In BM, a smaller Vb8+B220 population (0.5%) was
identified (Fig. 1), with only 60% of these cells Cb, reflecting 0.3%
of total BM. It is also notable that the level of Vb staining on
Vb8+Cb cells in BM is higher than that on the small population of
Vb8+Cb+ cells in BM. In thymus, a distinct population of 1.1% was
found to be Vb8+B220 cells (Fig. 1). Of these, only 5.5%, reflect-
ing 0.06% of total thymus, were Cb cells. In spleen, 3.3% of cells
were Vb8+B220, and only 9.1% of these were Cb, reflecting
0.3% of total spleen. Across all tissues, the percentage of Cb cells
among Vb8+B220 cells was greatest in BM, consistent with an
absence of mature T cells. One explanation is that Vb8+Cb cells
originate in BM, and migrate from BM to secondary lymphoid tis-
sues [17–21], consistent with the presence of a small number of
Ly5 allotype-distinct Vb8+Cb cells in the mesenteric lymph node,
thymus and spleen. We also noted the presence of a Vb8+B220+
subset present in mesenteric lymph node (0.3%) and spleen
(0.6%), not present in thymus.
Fig. 1 Identification of Vb8+Cb cells in murine lymphoid tissues. Cells were isolated from mesenteric lymph node, bone marrow, thymus and
spleen of BA mice. Each sample was stained with fluorochrome-conjugated antibodies specific for Vb8, Cb, NK1.1, Thy1.2 and B220. Antibody bind-
ing was measured by flow cytometry. Live (PI) B220 lymphoid cells were gated prior to delineating subsets of Vb8+Cb cells also shown to be
NK1.1 and Thy1. Numbers in quadrants reflect % positive staining cells among total viable lymphoid population in each tissue. Isotype control
antibody binding was used to set gates. Representative data are shown.
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The Vb8+Cb subset in BM and spleen contains
hematopoietic progenitors
The relationship between the Vb8+Cb subset in BM and other hema-
topoietic progenitor subsets was investigated flow cytometrically.
Subsets in spleen were also analysed since the spleen is the source
of the C1-V13D cell line, and contains hematopoietic stem/progenitor
cells [22]. Common lymphoid progenitors, distinguishable as c-
KitloSca-1loCD127(IL-7Ra)+ cells [15], reflect the proximate source of
T-cell progenitors in BM [23]. MPP as c-KithiSca-1hiCD127 cells in
BM also reflect a source of T-cell progenitors [24], in that they can
seed BM where they develop into CLP and later produce T cells in thy-
mus [23]. On the basis of our hypothesis that Vb8+Cb cells reflect
T-cell progenitors, the Vb8+Cb subsets in spleen and BM were
investigated primarily for expression of markers which delineate T-
cell progenitors from other hematopoietic progenitors.
Lin BM cells were prepared and stained with antibodies to Vb8
and Cb to gate the Vb8+Cb subset. This population was then analy-
sed for expression of c-Kit, Sca-1 and CD127, and distinct subsets of
c-Kit+ hematopoietic progenitors delineated (Fig. 2). Clear popula-
tions of Sca-1loc-KitloCD127+ (CLP-like) cells, Sca-1c-KithiCD127
[common myeloid progenitor (CMP)-like], but almost no Sca-1+/hic-
Kit+CD127 (HSC- or MPP-like) cells could be distinguished among
the Vb8+Cb subset of BM. The Sca-1+c-KitCD127 subset does
not resemble progenitors and could reflect lymphoid cells. The phe-
notypes of CLP, CMP, MPP and HSC with respect to these markers
have been described previously [15, 25, 26]. A summary of the per-
centage representation of these subsets among Lin BM, resorted
Lin BM and spleen is shown in Figure 2. While CMP-like and CLP-
like cells were present among the Vb8+Cb subset of spleen and BM,
the HSC-like or MPP-like subset was less well represented among the
BM subset.
This suggests that the Vb8+Cb subsets of spleen and BM could
contain a range of cells reflecting hematopoietic progenitors.
Differentiative potential of Vb8+Cb BM cells
following adoptive transfer into mice
On the basis of these results, it was has been suggested that the
Vb8+Cb subset of BM contains hematopoietic progenitors, and pos-
sibly T-cell progenitors, that develop into mature cells following adop-
tive transfer in vivo. A single time-point of 4 weeks was chosen as
sufficient time post-transfer to see the rapid development of T cells
from CLP, which should appear in thymus and spleen from 2 to
4 weeks. At 4 weeks, it is also possible to detect myeloid cells as the
earliest progeny of any HSC and MPP developing through a CMP
intermediate. Four weeks is also the earliest point at which lymphoid
progeny of HSC and MPP are evident in thymus and spleen from CLP
developing within BM [23].
Table 1 Lin
Vb8+Cb bone marrow progenitors lack T lineage potential
Adoptive
transfer
Cells given
Spleen
% Ly5.1+
cells
% among Ly5.1+ cells in spleen Thymus
% Ly5.1+
cells
% among Ly5.1+
cells in thymus
B cells
(CD19)
T cells
(Cb)
Gran/macro
(Gr-1/Mac-1)
B cells
(CD19)
T cells
(Cb)
Intrathymic Kit+LinSca1+ 0.69 4.4 87.0 1.5 11.2 5.0 51.8
Intrathymic LinVb8+Cb 0.17 99.0 1.2 0.6 0.001 0 0
Intravenous LinVb8+Cb 0.05 99.2 0 0 0 0 0
Intravenous* LinVb8+Cb 0 0 0 0 0 0 0
Intrathymic LinVb8Cb 0.29 2.66 69.0 0.76 31.9 0 46.1
Intravenous LinVb8Cb 7.3 94 0.1 0.61 3.5 2.5 75†
Intravenous LinVb8Cb 4.7 96 0.05 0.83 3.1 0.1 89‡
Intrathymic Nil/PBS 0 0 0 0 0 0 0
Intrasplenic Nil/PBS 0 0 0 0 0 0 0
Bone marrow cells from BA (C57BL/Ka-Ly5.1) mice were sorted twice to give pure Kit+LinSca1+, LinVb8+Cb and LinVb8Cb subsets.
500 cells were injected intravenously or intrathymically into sub-lethally irradiated (4.75 Gy) C57BL/Ka-Ly5.2 host mice. After 4 weeks, spleno-
cytes and thymocytes were stained with anti-Ly5.1 and anti-Ly5.2 antibodies for FACS detection of Ly5.1+ cells expressing the lineage markers
Cb, CD19, Mac1 and Gr-1. Thymocytes were also stained for the subset markers CD4 and CD8.
*Two of three mice given LinVb8+Cb cells showed donor cell development.
†Thymic subsets: CD4+ (16.3%), CD8+ (4.3%), CD4+CD8+ (73%).
‡Thymic subsets: CD4+ (14.0%), CD8+ (3.3%), CD4+CD8+ (80%).
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In a first experiment, 500 resorted LinVb8+Cb BM cells from
BA (Ly5.1) mice prepared as described in Figure 2 were intrathymi-
cally injected into sub-lethally irradiated (4.75 Gy) C57BL/Ka-Ly5.2
host mice. In parallel, control BM populations of sorted HSC (KLS
cells: c-Kit+LinSca+) or LinVb8Cb cells were prepared. Some
mice were injected with PBS to provide a control for inoculation and
for Ly5.1 and Ly5.2. In a second experiment, the same LinVb8+Cb
cells were given intravenously, but anti-Thy1.1 antibody was used in
place of anti-CD3e antibody for depletion of T cells, to preclude any
loss of T-cell precursors on the basis of CD3e expression. In this
experiment, the LinVb8Cb subset containing HSC and MPP was
sorted and served as a positive control for reconstitution. At 4 weeks
post-transfer, mice were killed and both splenocytes and thymocytes
collected and stained with antibodies specific to detect the presence
of cells of different hematopoietic lineages.
Adoptively transferred cells developing in spleen and thymus of
the Ly5.2 hosts were first identified as viable (PI) and then
assessed for expression of Ly5.1 and lineage markers. Control
Ly5.2 mice given PBS showed no staining for Ly5.1 (Table 1).
Markers used to detect cell development in thymus were specific
for early progenitors (c-Kit), immature T cells (CD44 and CD25),
mature ab T cells (TCR-Cb, CD3e, CD4, CD8), TCR-cd, NK and NK
T cells (NK1.1), mature B cells (B220, CD19, I-Ab) and dendritic
cells (CD11c, I-Ab). Figure 3 shows the staining profile of thymo-
cytes for one representative animal. Cell development in spleen
was assessed in terms of the frequency of donor-derived T cells
(Cb, CD4, CD8), B cells (CD19), macrophages (Mac1) and granulo-
cytes (Gr-1). Figure 4 shows the staining profile of splenocytes in
one representative animal.
Mice intrathymically injected with control HSC (KLS) cells showed
full reconstitution of every cell lineage common to spleen or thymus
as anticipated (Figs 3 and 4, and Table 1). Hematopoietic stem cells
gave rise to predominantly CD4+ and CD8+ single-positive T cells and
CD4+CD8+ double-positive T cells, and minor populations of TCR-cd+
T cells, MHC-II+ cells which could be dendritic cells and c-Kit+ cells in
very low number (0.02%) which could be progenitors (Fig. 3). The
presence of low numbers of B220+ B cells developing in the thymus
of mice given KLS cells (0.03%) has been reported previously [25,
27]. Amongst mice given LinVb8+Cb cells intrathymically, only 2
out of 3 showed reconstitution with donor cells. No T cells or B cells
were detected in the thymus of donor-reconstituted mice given
LinVb8+Cb cells (Fig. 3), although both showed clear B-cell devel-
A
B
Fig. 2 Analysis of Vb8+Cb cells among
bone marrow (BM) progenitors. A popula-
tion of Lin BM was prepared from BA
(C57BL/Ka-Ly5.1) mice and cells were
stained with fluorochrome-conjugated
antibodies specific for Vb8, Cb, CD127,
Sca-1 and c-Kit. FACS analysis was used
to distinguish cell subsets. (A) Viable
(PI) lymphoid cells were gated initially
on the basis of Side Scatter (SSC) and
then Vb8+Cb cells were gated for analy-
sis of marker expression of c-Kit, Sca-1
and CD127 markers to delineate hemato-
poietic progenitors. Numbers in quadrants
reflect % cells staining relative to the ini-
tial gated population of viable lymphoid
cells. (B) Size comparison of subsets iso-
lated from total lineage depleted (Lin)
BM, resorted LinBM and spleen.
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opment in spleen with no evidence of T cell or myeloid development
in that organ (Fig. 4). Since CD19 is a marker of both early B cells
and more mature B cells, there results are consistent with
LinVb8+Cb cells containing a restricted B lymphoid progenitor that
can develop in spleen following intravenous transfer, and can also
localize in spleen following intrathymic transfer (Table 1). This result
contradicts our conclusion in Figure 2, that the Vb8+Cb subsets in
spleen could contain multipotent hematopoietic progenitors, and
instead appears to contain specifically B-cell progenitors.
For mice given LinVb8+Cb BM cells, the absence of T-cell
production precludes the presence of T-cell progenitors among
this subset. The absence of myeloid cell development in spleen
also precludes the presence of HSC or MPP among this subset.
The production of B cells and their localization in spleen but not
thymus is also consistent with evidence of Vb8+B220+ cells in
peripheral mesenteric lymph node and spleen but not thymus
(Fig. 1). Since LinVb8+Cb cells develop into B cells in spleen
following either intravenous or intrathymic inoculation, it is not yet
clear whether splenic B cells derive from progenitors that differen-
tiate within the thymus and then enter spleen, or from progenitors
which differentiate within spleen itself. Overall, our reconstitution
experiments indicate the presence of a B cell restricted lymphoid
progenitor among the LinVb8+Cb subset of BM. The inability to
generate T-cell progeny following intrathymic inoculation of
progenitors also supports the argument that this subset contains
B-cell progenitors and not T-cell progenitors. The absence of mye-
loid progeny also demonstrates an absence of HSC or MPP
among the LinVb8+Cb subset of BM.
Discussion
Here, the hypothesis is investigated that Vb8+Cb cells in BM rep-
resent T-cell progenitors and that the expressed Vb8 peptide
encoded from germline genes is a marker of these cells. Vb8+Cb
non-B cells (B220) were identified in several organs including thy-
mus, mesenteric lymph nodes, BM and spleen of mice. To some
extent these subsets resemble C1-V13D, described previously as
an immature spleen-derived T-cell line expressing TCR-Vb8.2 pep-
tides as well as germline Vb8.2 transcripts [28]. The Vb8+Cb sub-
set of BM and spleen was therefore analysed for expression of c-
Kit, Sca-1 and CD127 markers, which distinguish CLP from other
progenitor populations in BM. An initial study of c-Kit, CD127 and
Sca-1 expression on a gated Vb8+Cb subset of whole spleen and
A B
C
Fig. 3 Absence of T-cell progenitors in LinVb8+Cb bone marrow. A population of Lin BM was prepared from BA (C57BL/Ka-Ly5.1) mice. Cells
were sorted twice to give c-Kit+Sca-1+Lin (KLS) and LinVb8+Cb cells. Five hundred cells were injected intrathymically into sub-lethally irradiated
(4.75 Gy) C57BL/Ka-Ly5.2 mice. After 4 weeks, thymocytes were stained in three different stainings (A–C) with anti-Ly5.1 and anti-Ly5.2 antibodies
for flow cytometric detection of Ly5.1+ cells expressing the lineage markers TCR-Cb, CD4, CD8, CD3e, TCRcd, NK1.1, I-Ab, CD11c, B220, CD44,
CD25 and c-Kit. Numbers in quadrants reflect % Ly5.1+ cells expressing lineage markers. The staining profile and subset analysis of a single animal
are shown. Further animal analyses are summarized in Table 1.
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BM revealed multiple sub-populations phenotypically resembling
HSC, MPP, CMP and CLP.
The hypothesis that the Vb8+Cb subset contains lymphoid pro-
genitors was based on transcriptional evidence that both early T and
B cells express GL-Vb8.2 transcripts [4, 6]. Following both intrathy-
mic and intravenous transfer of LinVb8+Cb cells isolated from BM,
no development of T cells was detected in thymus or spleen, and fur-
ther development of LinVb8+Cb BM cells was found to be limited
to B lymphopoiesis. While B cells can arise in low numbers as an
endogenous thymic cell population [27, 29], Vb8+Cb B cells were
instead detected in spleen in the absence of any thymic B-cell devel-
opment. It is not yet possible to determine whether development of
these B cells occurred in spleen itself, or was dependent on lodge-
ment of progenitors in BM.
Results presented here contrast with previous evidence that the
C1-V13D cell line, representing a splenic Vb8+Cb cell line, can
undergo some T-cell differentiation upon intrathymic transfer show-
ing TCRab expression [28]. It is possible that the LinVb8+Cb sub-
set from BM contains lymphoid progenitors with capacity to
differentiate into only B cells, while a similar or equivalent subset resi-
dent in spleen may have T-cell differentiative potential. Such a model
invokes a heterogeneous population of progenitors in mice express-
ing germline Vb8 peptide. This is supported by evidence for expres-
sion of GL-Vb8.2 transcripts in many cell types including early T
cells, early B cells, BM progenitors and early dendritic cells (Abbey &
O’Neill, unpublished data). Indeed, C1-V13D has been shown to
express low levels of early T-cell markers including CD3e [28]. It is
also important to note that lineage depletion using anti-CD3e antibody
would also deplete CLP known to express this marker [15]. However,
depletion with anti-Thy1.1 did not reveal a CLP with T-cell differentia-
tive capacity even after intrathymic inoculation. The LinVb8+Cb BM
subset therefore appears to contain a later lymphoid progenitor com-
mitted to the B-cell lineage.
The LinVb8+Cb BM population does not appear to contain bi-
potent CLP-like cells with capacity to differentiate into both T and B
cells. In terms of bipotent lymphoid potential, thymic DN1 cells are
known to be heterogeneous with specific sub-populations retaining
ability to give rise to B cells [30]. While bipotent T and B progenitors
can give rise to B cells in thymus, this does not appear to be the case
for the LinVb8+Cb BM subset [27, 29]. In fact, the progenitor
Fig. 4 Differentiative potential of LinVb8+Cb bone marrow cells. In the experimental protocol described in Figure 3, marker expression was analy-
sed on Ly5.1+ cells present among splenocytes at 4 weeks after intrathymic transfer of LinVb8+Cb BM cells. Splenocytes were stained with anti-
bodies for 5-colour flow cytometric detection of Ly5.1+ cells expressing lineage markers Cb, CD8, CD4, CD19, Mac1 and Gr-1. Numbers in
quadrants reflect % Ly5.1+ cells expressing lineage markers. The staining profile and subset analysis of a single animal are shown. Further animal
analyses are summarized in Table 1.
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described here appears to have properties more closely resembling
the CLP-2 cell type, which can seed thymus and differentiate into B
cells [31]. However since the LinVb8+Cb cell subset does not
express B220, it is distinct from the CLP-2 population identified in BM
as a B220+ cell [31].
Mesenteric lymph nodes may also be an important source of
Vb8+Cb cells [12]. Mesenteric lymph nodes have also been
described as a site for extra-thymic T-cell development [17–21]. Con-
sistent with this evidence is the finding that subsets of
Vb8+CbB220+ cells exist in BM (0.07%) and mesenteric lymph node
(0.12%) of BA mice, but not in spleen and thymus (Fig. 1). A further
question to be addressed is whether a Vb8+CbB220 subset is a
precursor of Vb8+CbB220+ cells in these tissues. The relationship
between Vb8+CbB220+ subsets detectable in these tissues and the
B-cell populations produced in reconstitution studies also needs to be
addressed further.
Evidence for germline transcription of TCR-Vb genes leading to
expression of a cell surface peptide in B-cell progenitors raises ques-
tions of their functional role. Models for function should take into
account the prevalence of Vb8 peptide-expressing cells in multiple
organs, and in both mature and immature lymphoid cells. Many
attempts to investigate cell surface expression of germline TCR-
Vb8.2 expression on the surface of TCR-Cb cells by immunoprecipi-
tation and Western blotting have been unsuccessful. Preliminary
experiments have shown that this protein is not GPI-anchored on the
cell surface (Abbey & O’Neill, unpublished data). It is possible that a
truncated TCR-b chain with no transmembrane region is expressed
only and then is secreted by cells. Such transitional expression could
also account for the variable expression reported for TCR-Vb8.2 on
the surface of C1-V13D cells [2]. Transfection of germline TCR-Vb8.2
genes into C1-V13D cells was used to overcome this problem in dem-
onstrating cell surface expression [32]. Candidate molecules that
could be involved in a cell surface complex with TCR-Vb8.2 could
include pTa and CD3e, each of which is expressed by C1-V13D
(Abbey & O’Neill, unpublished data).
One possible role for germline-encoded TCR-Vb peptides could
be generation of tolerance to T cells in vivo. A substantial level of
diversity exists within the TCR and BCR repertoire against which
developing T and B lymphocytes must be tolerized. Therefore, germ-
line-encoded Ig or TCR proteins may play an antigenic role in this
process within thymus for T-cell development, or within BM, spleen
and lymph node for B-cell development. The expression of multiple
germline TCR-Vb transcripts in the cloned C1-V13D cell line also
supports this model [5].
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